Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Agn 194204
2. Agn-194204
3. Agn194204
4. Nrx 194204
5. Nrx-194204
6. Nrx194204
1. 220619-73-8
2. Agn194204
3. Irx4204
4. Vtp-194204
5. Agn-194204
6. Nrx194204
7. Nrx-194204
8. Chembl75133
9. Iso Irx-a
10. 877m97z38y
11. Vtp 194204
12. (+)-vtp-194204
13. (2e,4e)-3-methyl-5-((1s,2s)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)penta-2,4-dienoic Acid
14. Agn 194204
15. (2e,4e)-3-methyl-5-[(1s,2s)-2-methyl-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]penta-2,4-dienoic Acid
16. Nrx 194204
17. Schembl3437269
18. Unii-877m97z38y
19. 3-methyl-5-[2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-cyclopropyl]-penta-2,4-dienoic Acid
20. Agn 4204
21. Irx-4204
22. Nrx 4204
23. Bdbm50101445
24. Akos040741057
25. Db11806
26. Da-70643
27. Hy-13717
28. Ms-25475
29. Pd119160
30. Kb-145960
31. Cs-0007745
32. Ns00068655
33. E98723
34. Irx4204;nrx194204;vtp 194204
35. Q27269803
36. (2e,4e)-3-methyl-5-[(1s,2s)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-cyclopropyl]-penta-2,4-dienoic Acid
| Molecular Weight | 352.5 g/mol |
|---|---|
| Molecular Formula | C24H32O2 |
| XLogP3 | 7.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 37.3 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 624 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
41
PharmaCompass offers a list of IRX4204 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right IRX4204 manufacturer or IRX4204 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred IRX4204 manufacturer or IRX4204 supplier.
PharmaCompass also assists you with knowing the IRX4204 API Price utilized in the formulation of products. IRX4204 API Price is not always fixed or binding as the IRX4204 Price is obtained through a variety of data sources. The IRX4204 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A IRX4204 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IRX4204, including repackagers and relabelers. The FDA regulates IRX4204 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IRX4204 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A IRX4204 supplier is an individual or a company that provides IRX4204 active pharmaceutical ingredient (API) or IRX4204 finished formulations upon request. The IRX4204 suppliers may include IRX4204 API manufacturers, exporters, distributors and traders.
IRX4204 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IRX4204 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right IRX4204 GMP manufacturer or IRX4204 GMP API supplier for your needs.
A IRX4204 CoA (Certificate of Analysis) is a formal document that attests to IRX4204's compliance with IRX4204 specifications and serves as a tool for batch-level quality control.
IRX4204 CoA mostly includes findings from lab analyses of a specific batch. For each IRX4204 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IRX4204 may be tested according to a variety of international standards, such as European Pharmacopoeia (IRX4204 EP), IRX4204 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IRX4204 USP).
